[
  {
    "ts": null,
    "headline": "Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction",
    "summary": "RAHWAY, N.J., August 30, 2025--Merck Provides New Results for Vericiguat in Patients with Chronic Heart Failure and Reduced Ejection Fraction. Results presented at ESC 2025",
    "url": "https://finnhub.io/api/news?id=53754bff4a8e8c3ff9f9f10e3c3196f83bcd4119c1fa372fbf21caff0e3023b6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756536300,
      "headline": "Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction",
      "id": 136579624,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., August 30, 2025--Merck Provides New Results for Vericiguat in Patients with Chronic Heart Failure and Reduced Ejection Fraction. Results presented at ESC 2025",
      "url": "https://finnhub.io/api/news?id=53754bff4a8e8c3ff9f9f10e3c3196f83bcd4119c1fa372fbf21caff0e3023b6"
    }
  }
]